Troisi Nicola, Bertagna Giulia, Lepidi Sandro, Berchiolli Raffaella, Badalamenti Giovanni, D'Oria Mario
Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Division of Vascular and Endovascular Surgery, Cardiovascular Department, University Hospital of Trieste ASUGI, Trieste, Italy.
J Vasc Surg. 2025 Jul 8. doi: 10.1016/j.jvs.2025.06.049.
In the present study, we aimed to evaluate in detail the late outcomes of the overall endovascular cohort of the PARADE study, with a focus on factors that could influence such outcomes as these may provide useful insights for patients and clinicians alike.
Between January 2010 and December 2023 patients with nonacute elective popliteal artery aneurysms undergoing endovascular exclusion with the Viabahn stent graft were included in a multicenter retrospective cohort study (40 sites from 10 countries). A cut-off of 15 procedures was used to define a participating center as high volume (>15) or low volume (<15).
During the 14-year studied period, 326 patients were treated who met inclusion criteria for the present study. Patients were predominantly male (304, 93.3%) with a mean age of 74.6 ± 9.2 years. Most patients were asymptomatic (221 [67.8%]); 56 (17.2%) had intermittent claudication and 49 (15%) chronic limb-threatening ischemia. Acute technical success was not obtained in two cases (0.6%), owing to residual type Ia endoleak (one case), and residual type Ib endoleak (one case). Of these, one patient underwent an open conversion, whereas the other one was followed up because unfit for any type of reintervention. At 30 days, two patients died with an overall 30-day mortality rate of 0.6%. Both were not cardiovascular deaths related to interventions. In addition, 30-day rates of major adverse cardiovascular events, graft occlusion, and procedure-related reinterventions were 1.2%, 3.7%, and 5.2%, respectively. No patient underwent early major amputation. The 5-year Kaplan-Meier estimates of primary patency, secondary patency, freedom from reinterventions(s), and amputation-free survival were 65.8% (95% confidence interval [CI], 61.7%-71.9%), 84.9% (95% CI, 78.7%-89.1%), 70.5% (95% CI, 66.2%-74.8%), and 98.2% (95% CI, 96.4%-99.6%), respectively. Amputation-free survival was adversely affected by active smoking (P = .011), chronic kidney disease (P < .001), poor run-off status (P = .042), and low number of cases for each center (<15) (P = .011). Multivariate analysis reported an approaching significance for active smoking (hazard ratio, 3.460; 95% CI, 2.6-6.1; P = .051), and confirmed the association with chronic kidney disease (hazard ratio, 7.413; 95% CI, 5.4-9.3; P = .006).
The findings from this study show that endovascular repair using the Viabahn stent graft may provide a feasible technical option for elective treatment of popliteal artery aneurysm. Some patient-related and procedure-related factors were identified, including chronic kidney disease, that were associated with higher rates of long-term complications.
